Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024
2023 年 10 月至 2024 年 1 月，西班牙 nirsevimab 免疫预防对婴儿因呼吸道合胞病毒下呼吸道感染住院的有效性的早期评估
期刊:Eurosurveillance
影响因子:9.9
doi:10.2807/1560-7917.ES.2024.29.6.2400046
Mónica López-Lacort, Cintia Muñoz-Quiles, Ainara Mira-Iglesias, F Xavier López-Labrador, Beatriz Mengual-Chuliá, Carlos Fernández-García, Mario Carballido-Fernández, Ana Pineda-Caplliure, Juan Mollar-Maseres, Maruan Shalabi Benavent, Francisco Sanz-Herrero, Matilde Zornoza-Moreno, Jaime Jesús Pérez-
